Evidence mapPaperPMID 39498034Full record

ArticleHeliyon2024

Mesoporous activated carbon derived from Chinese herbal medicine residues for hemoperfusion removal of uremia toxins from progressive chronic kidney diseases patients.

Chengyu Yang, Lipeng Diao, Zhuo Song, Chen Guan, Lingyu Xu, Quandong Bu, Wei Jiang, Huiqing Yu, Daohao Li, Yan Xu

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chengyu YangDepartment of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, PR China.
Lipeng DiaoState Key Laboratory of Bio-fibers and Eco-textiles, College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, PR China.
Zhuo SongDepartment of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, PR China.
Chen GuanDepartment of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, PR China.
Lingyu XuDepartment of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, PR China.
Quandong BuDepartment of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, PR China.
Wei JiangDepartment of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, PR China.
Huiqing YuSchool of Basic Medicine, Qingdao University, Qingdao, 266071, PR China.
Daohao LiState Key Laboratory of Bio-fibers and Eco-textiles, College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, PR China.
Yan XuDepartment of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemoperfusion is one of the most important therapies for progressive chronic kidney disease (CKD) and is effective at removing toxins from the blood. Increasing the efficiency of adsorbents applied in hemoperfusion is crucial. In the present study, shell of areca nut, one of the most common waste Chinese herb medicine residue with a porous structure was carbonized and activated at different temperatures to obtain two kinds of porous materials. The biocompatibility of the as-prepared porous materials was estimated via a hemolytic test, and the removal efficiency of the materials toward toxins was tested via an adsorption experiment in solution and blood samples from CKD patients, simulated hemoperfusion and in vivo hemoperfusion. After 4 h of adsorption, free and protein-bound toxins in solution were efficiently removed by the prepared porous materials, and the removal efficiency was better than that of commonly used hemoperfutor adsorbents. Most of the tested toxins can be removed from CKD blood samples and simulated hemoperfusion samples. Blood uremic toxins from CKD mice were also efficiently and safely removed after in vivo hemoperfusion using the as-prepared adsorbent. This work highlights promising adsorbents for hemoperfusion that could increase the therapeutic efficacy in patients with progressive CKD.

Indexed as

Activated carbonChinese herbal medicine residuesHemoperfusionUremia toxins

Identifiers

PMID39498034
PMCPMC11533571

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.